tiprankstipranks

Lauren Silvernail Insider Profile

4 Followers
Lauren Silvernail, CFO & CBO at Revance Therapeutics, holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP), holds 141.57K shares in Evolus (Ticker: EOLS), holds 65.50K shares in Revance Therapeutics (Ticker: RVNC).
tipranks
Lauren Silvernail

Lauren Silvernail
Revance Therapeutics (RVNC)
CFO & CBO

Ranked #15,548 out of 98,624 Corporate Insiders

Profitable Transactions

57%
4 out of 7 Profitable Transactions

Average Return

+15.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
87.79%
12.21%
0.00%
A breakdown of Lauren Silvernail's holdings

Insider Roles

Evolus
(EOLS)
CFO and EVP, Corporate Development
Revance Therapeutics
(RVNC)
CFO & CBO
Harrow Health
(HROW)
Director
Roles that Lauren Silvernail holds in companies

Most Profitable Insider Trade

Stock:
Revance Therapeutics
(RVNC)
Rating:Informative Buy
Date:Dec 12, 2014 - Dec 12, 2015
Return:+101.20%
The most profitable trade made by Lauren Silvernail

Lauren Silvernail's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Revance Therapeutics
May 24, 2018
CFO & CBO
Uninformative Sell
86.91K
$248.56K
Evolus
May 18, 2022
CFO and EVP, Corporate Development
Informative Sell
871.38K
$1.79M
HARP
Harpoon Therapeutics
Mar 11, 2024
Uninformative Sell
$0.00
Harrow Health
Director
List of latest transactions for each holding click on a transaction to see Lauren Silvernail's performance on stock

Lauren Silvernail insider profile FAQ

What is the percentage of profitable transactions made by Lauren Silvernail?
The percentage of profitable transactions made by Lauren Silvernail is 57%.
    What is the average return per transaction made by Lauren Silvernail?
    The average return per transaction made by Lauren Silvernail is 15.10%.
      What stocks does Lauren Silvernail hold?
      Lauren Silvernail holds: RVNC, EOLS, HARP, HROW stocks.
        What was Lauren Silvernail’s latest transaction?
        Lauren Silvernail latest transaction was an Uninformative Sell of ―.
          What was Lauren Silvernail's most profitable transaction?
          Lauren Silvernail’s most profitable transaction was an Informative Buy of RVNC stock on December 12, 2014. The return on the trade was 101.20%.
            What is Lauren Silvernail's role in Revance Therapeutics?
            Lauren Silvernail's role in Revance Therapeutics is CFO & CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.